Supplementary Material for: The Global Macroeconomic Burden of Neurological Disorders

Read full text Summarise with VIRAT
Authors: figshare admin karger, Ouyang L, Shan X., Sun X., Peng J., Ye H., Wen Y., Xiao F., Zhu H., Zhang Z., Guo H., Kuang W
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Existing studies have focused on neurological disorders’ morbidity and mortality, yet their economic consequences remain unquantified. We estimated the macroeconomic impact of neurological disorders and subcategories at the global, super-regional, and national levels in 2019 and 2021, and described sex and age distribution. Methods: We obtained mortality and morbidity data, reflecting long-run and short-run disease burden respectively, from the Institute of Health Metrics and Evaluation (IHME) Global Burden of Disease 2021 study. Purchasing power parity (PPP)-adjusted gross domestic product (GDP) data were sourced from the World Bank. Economic burden was estimated using the value of lost welfare (VLW) framework, which rests on the value of a statistical life (VSL) and covers non-market losses. All monetary values are expressed in 2021 international dollars adjusted for PPP. Results: In 2021, the global VLW of neurological disorders was $10,710.51 billion, equal to 7.23% of global gross domestic product (GDP), and the short-run economic burden predominates over the long-run component. By subcategories, headache disorders accounted for 44.7%, and Alzheimer’s disease and other dementias for 35.7%. From 2019 to 2021, global VLW changed little, while VLW/GDP (%) declined slightly due to rising nominal GDP. Conclusions: Neurological disorders impose substantial economic burden globally, particularly in High-income super-region and older populations. Policy emphasis should reflect regional burden profiles. High-income settings prioritize earlier dementia detection, life-course risk-factor control, and caregiver support., while low- and middle-income settings scale primary-care chronic management and effective acute headache therapies.

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Mental Health Treatment and Access Global Health Care Issues

Publication details

Journal / source
Figshare
Publication date
19 March 2026
Language
EN